Skip to main content
. 2016 Mar 22;7:312. doi: 10.3389/fmicb.2016.00312

FIGURE 2.

FIGURE 2

Lymphoproliferative response in PBMCs of treated VL patients in response to 15 recombinant proteins and SLD (10 μg/ml each). Each bar represents the pooled data (mean ± SE). Significance values indicate the difference in stimulation between the SLD and the recombinant proteins (*p < 0.05, **p < 0.01, and ***p < 0.001).